Literature DB >> 10944493

Effect of transfusional iron overload on immune response.

S Cunningham-Rundles1, P J Giardina, R W Grady, C Califano, P McKenzie, M De Sousa.   

Abstract

Increased susceptibility to infectious disease is observed in persons with transfusion-dependent thalassemia and iron overload who experience increased exposure to pathogens and chronic immune stimulation. An abnormal low CD8(+) T (LT8) immune phenotype defines a subgroup of patients. The CD8(+) T cell immunophenotype is stable despite continued blood transfusion and is independent of age. CD8(+) T cells, but not CD4(+) T cells, were modulated during intravenous chelation with deferoxamine. Return to characteristic pretreatment levels of CD8 was observed in both the low and the normal groups, suggesting the possibility of a set point. Proliferative response to mitogens and antigens was increased by chelation. Because CD8(+) T cells are important in immune response to infectious disease, these studies suggest that intrinsic CD8(+) T cell subset differences may be a critical factor in determining susceptibility to infection independent of transfusional iron overload or alloantigen exposure.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10944493     DOI: 10.1086/315919

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  18 in total

Review 1.  Role of nutrients in the development of neonatal immune response.

Authors:  Susanna Cunningham-Rundles; Hong Lin; Deborah Ho-Lin; Ann Dnistrian; Barrie R Cassileth; Jeffrey M Perlman
Journal:  Nutr Rev       Date:  2009-11       Impact factor: 7.110

2.  Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy.

Authors:  Robert S Nickel; Ifeyinwa Osunkwo; Aneesah Garrett; Jennifer Robertson; David R Archer; Daniel E L Promislow; John T Horan; Jeanne E Hendrickson; Leslie S Kean
Journal:  Br J Haematol       Date:  2015-03-05       Impact factor: 6.998

Review 3.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 4.  Anaemia in inflammatory rheumatic diseases.

Authors:  Günter Weiss; Georg Schett
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

5.  Nifedipine affects the course of Salmonella enterica serovar Typhimurium infection by modulating macrophage iron homeostasis.

Authors:  Sabine M Mair; Manfred Nairz; Rosa Bellmann-Weiler; Thomas Muehlbacher; Andrea Schroll; Igor Theurl; Patrizia L Moser; Heribert Talasz; Ferric C Fang; Guenter Weiss
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

6.  Host iron withholding demands siderophore utilization for Candida glabrata to survive macrophage killing.

Authors:  Tracy Nevitt; Dennis J Thiele
Journal:  PLoS Pathog       Date:  2011-03-17       Impact factor: 6.823

7.  Total blood lymphocyte counts in hemochromatosis probands with HFE C282Y homozygosity: relationship to severity of iron overload and HLA-A and -B alleles and haplotypes.

Authors:  James C Barton; Ronald T Acton; Howard W Wiener; Rodney Cp Go
Journal:  BMC Blood Disord       Date:  2005-07-25

8.  Anti-leukemic properties of deferasirox via apoptosis in murine leukemia cell lines.

Authors:  Sol-Rim Jeon; Jae-Wook Lee; Pil-Sang Jang; Nack-Gyun Chung; Bin Cho; Dae-Chul Jeong
Journal:  Blood Res       Date:  2015-03-24

Review 9.  Iron supplementation in the intensive care unit: when, how much, and by what route?

Authors:  Marc Lapointe
Journal:  Crit Care       Date:  2004-06-14       Impact factor: 9.097

Review 10.  Electrostatic potential on human leukocyte antigen: implications for putative mechanism of chronic beryllium disease.

Authors:  James A Snyder; Ainsley Weston; Sally S Tinkle; Eugene Demchuk
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.